Controlling the Burden of COVID-19 by Manipulating Host Metabolism

Viral Immunol. 2022 Jan-Feb;35(1):24-32. doi: 10.1089/vim.2021.0150. Epub 2021 Dec 13.

Abstract

The coronavirus disease 2019 (COVID-19) pandemic caused by the coronavirus-severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) continues to cause global health problems, but its impact would be minimized if the many effective vaccines that have been developed were available and in widespread use by all societies. This ideal situation is not occurring so other means of controlling COVID-19 are needed. In this short review, we make the case that manipulating host metabolic pathways could be a therapeutic approach worth exploring. The rationale for such an approach comes from the fact that viruses cause metabolic changes in cells they infect, effective host defense mechanisms against viruses requires the activity of one or more metabolic pathways, and that hosts with metabolic defects such as diabetes are more susceptible to severe consequences after COVID-19. We describe the types of approaches that could be used to redirect various aspects of host metabolism and the success that some of these maneuvers have had at controlling other virus infections. Manipulating metabolic activities to control the outcome of COVID-19 has to date received minimal attention. Manipulating host metabolism will never replace vaccines to control COVID-19 but could be used as an adjunct therapy to the extent of ongoing infection.

Keywords: COVID-19; consequence; immunity; long COVID; metabolism; outcome.

Publication types

  • Research Support, N.I.H., Extramural
  • Review

MeSH terms

  • COVID-19* / metabolism
  • COVID-19* / therapy
  • Cost of Illness*
  • Humans
  • Pandemics
  • SARS-CoV-2